结直肠腺瘤风险分类系统的比较:一项病例队列研究
该病例队列研究纳入675例结直肠癌病例和906例随机亚队列个体,比较传统、ESGE 2020和新颖三种腺瘤分类系统。与传统分类相比,ESGE 2020和新颖分类分别减少13.9%和44.2%需频繁监测人数,分别延迟1例(3.4%)和7例(24.1%)癌症诊断。结论认为ESGE 2020和新颖分类可大幅减少腺瘤切除后结肠镜监测所需资源。
要点
- 传统分类下52.7%腺瘤患者为高风险,ESGE 2020为45.2%,新颖分类为27.0%。
- 高风险者结直肠癌发病率传统479、ESGE 2020 552、新颖690/10万人年。
- 与传统分类比,ESGE 2020和新颖分类分别减少13.9%和44.2%需频繁监测人数。
核心结论
- 使用ESGE 2020和新颖风险分类将大幅减少腺瘤切除后结肠镜监测所需资源。
研究设计与样本
- 病例队列研究,纳入1993至2007年间切除腺瘤的个体,包括675例结直肠癌病例(腺瘤切除后中位5.6年诊断)和906例随机选择的亚队列个体。
主要发现
- 传统分类下430例(52.7%)为高风险,ESGE 2020分类下369例(45.2%)为高风险,新颖分类下220例(27.0%)为高风险。
- 高风险个体结直肠癌发病率分别为传统479、ESGE 2020 552、新颖690每10万人年;低风险个体分别为123、124、179每10万人年。
- 与传统分类相比,ESGE 2020和新颖分类分别减少13.9%和44.2%需频繁监测人数。
- 与传统分类相比,ESGE 2020和新颖分类分别延迟1例(3.4%)和7例(24.1%)癌症诊断。
关键数值与推荐
- 传统分类高风险:直径≥10 mm、高级别异型增生、绒毛状生长模式或3个及以上腺瘤。
- ESGE 2020分类高风险:直径≥10 mm、高级别异型增生或5个及以上腺瘤。
- 新颖分类高风险:直径≥20 mm或高级别异型增生。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Because post-polypectomy surveillance uses a growing proportion of colonoscopy capacity, more targeted surveillance is warranted. We therefore compared surveillance burden and cancer detection using 3 different adenoma classification systems. METHODS: In a case-cohort study among individuals who had adenomas removed between 1993 and 2007, we included 675 individuals with colorectal cancer (cases) diagnosed a median of 5.6 years after adenoma removal and 906 randomly selected individuals (subcohort). We compared colorectal cancer incidence among high- and low-risk individuals defined according to the traditional (high-risk: diameter ≥10 mm, high-grade dysplasia, villous growth pattern, or 3 or more adenomas), European Society of Gastrointestinal Endoscopy (ESGE) 2020 (high-risk: diameter ≥10 mm, high-grade dysplasia, or 5 or more adenomas), and novel (high-risk: diameter ≥20 mm or high-grade dysplasia) classification systems. For the different classification systems, we calculated the number of individuals recommended frequent surveillance colonoscopy and estimated number of delayed cancer diagnoses. RESULTS: Four hundred and thirty individuals with adenomas (52.7%) were high risk based on the traditional classification, 369 (45.2%) were high risk based on the ESGE 2020 classification, and 220 (27.0%) were high risk based on the novel classification. Using the traditional, ESGE 2020, and novel classifications, the colorectal cancer incidences per 100,000 person-years were 479, 552, and 690 among high-risk individuals, and 123, 124, and 179 among low-risk individuals, respectively. Compared with the traditional classification, the number of individuals who needed frequent surveillance was reduced by 13.9% and 44.2%, respectively, and 1 (3.4%) and 7 (24.1%) cancer diagnoses were delayed using the ESGE 2020 and novel classifications. CONCLUSIONS: Using the ESGE 2020 and novel risk classifications will substantially reduce resources needed for colonoscopy surveillance after adenoma removal.
引用
- Jodal HC, Wieszczy-Szczepanik P, Klotz D, et al. A Comparison of Risk Classification Systems of Colorectal Adenomas: A Case-Cohort Study. Gastroenterology. 2023. PMID: 37146913. doi:10.1053/j.gastro.2023.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。